Related Experiment Video
Updated: Jun 21, 2026

Visualization of Vascular and Parenchymal Regeneration after 70% Partial Hepatectomy in Normal Mice
Published on: September 13, 2016
Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography
Mai-Lin Chen1, Qing-Yu Zeng, Jian-Wei Huo
1Department of Radiology, China Meitan General Hospital, 29 Xibahe Nanli, Chaoyang District, Beijing 100028, China. miningchen@gmail.com
Insights
Perfusion computed tomography (CT) reveals significant hepatic microvascular changes in liver cirrhosis patients. Decompensated cirrhosis shows decreased mean transit time (MTT) and increased permeability surface area product (PS).
Area of Science:
- Radiology
- Hepatology
- Medical Imaging
Background:
- Liver cirrhosis is a chronic liver disease characterized by fibrosis and altered liver architecture.
- Hepatic microvascular dysfunction is a key feature of cirrhosis progression.
- Quantitative assessment of microvascular parameters is crucial for understanding disease severity.
Purpose of the Study:
- To evaluate hepatic microvascular parameters in liver cirrhosis using perfusion computed tomography (CT).
- To compare microvascular parameters between healthy controls and patients with compensated and decompensated cirrhosis.
Main Methods:
- Perfusion CT was performed on 29 healthy controls and 39 liver cirrhosis patients (22 compensated, 17 decompensated).
- Hepatic microvascular parameters, including mean transit time (MTT) and permeability surface area product (PS), were calculated using Perfusion 3 software.
- CT cine-scans were acquired after contrast agent injection.
Main Results:
- Statistically significant differences in MTT and PS were observed across the groups (P=0.010 for MTT, P=0.002 for PS).
- Decompensated cirrhotic patients exhibited significantly decreased MTT (P=0.017) and remarkably increased PS (P=0.001) compared to controls.
- MTT values were 15.6±4.2s (controls), 12.6±4.8s (compensated), and 11.7±4.6s (decompensated).
- PS values were 18.9±7.2, 22.8±8.4, and 28.7±13.1 mL/min per 100 mL for the respective groups.
Conclusions:
- Perfusion CT enables quantitative assessment of hepatic microvascular changes in liver cirrhosis.
- Significant alterations in hepatic microvascular parameters (MTT and PS) are evident in decompensated cirrhosis.
Aim:
To assess the hepatic microvascular parameters in patients with liver cirrhosis by perfusion computed tomography (CT).
Methods:
Perfusion CT was performed in 29 patients without liver disease (control subjects) and 39 patients with liver cirrhosis, including 22 patients with compensated cirrhosis and 17 patients with decompensated cirrhosis, proved by clinical and laboratory parameters. CT cine-scans were obtained over 50 s beginning with the injection of 50 mL of contrast agent. Hepatic microvascular parameters, mean transit time (MTT) and permeability surface area product (PS) were obtained with the Perfusion 3 software (General Electric, ADW 4.2).
Results:
The overall differences of MTT and PS between control subjects, patients with compensated cirrhosis and those with decompensated cirrhosis were statistically significant (P = 0.010 and P = 0.002, respectively). MTT values were 15.613 +/- 4.1746 s, 12.592 +/- 4.7518 s, and 11.721 +/- 4.5681 s for the three groups, respectively, while PS were 18.945 +/- 7.2347 mL/min per 100 mL, 22.767 +/- 8.3936 mL/min per 100 mL, and 28.735 +/- 13.0654 mL/min per 100 mL. MTT in decompensated cirrhotic patients were significantly decreased compared to controls (P = 0.017), whereas PS values were remarkably increased (P = 0.001).
Conclusion:
The hepatic microvascular changes in patients with liver cirrhosis can be quantitatively assessed by perfusion CT. Hepatic microvascular parameters (MTT and PS), as measured by perfusion CT, were significantly altered in decompensated cirrhosis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

